A. Sánchez

发表

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

X. Montalban, J. Lechner-Scott, E. Urcelay, 2011, Journal of Neuroimmunology.

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

F. Matesanz, X. Montalban, F. Reverter, 2012, Multiple sclerosis.

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis

X. Montalban, J. Río, M. Comabella, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Multiple sclerosis associates with LILRA3 deletion in Spanish patients

M. López-Botet, E. Ramil, J. Martínez-Rodríguez, 2009, Genes and Immunity.

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.

X. Montalban, J. Río, M. Prinz, 2009, Brain : a journal of neurology.

Neuroprotective agents: cannabinoids.

Antonio J. Sánchez, A. Sánchez, A. García‐Merino, 2012, Clinical immunology.

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2001, Synapse.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients

X. Montalban, J. Río, M. Comabella, 2018, Journal of Neuroinflammation.

Cellular immune responses in multiple sclerosis patients treated with interferon‐beta

X. Montalban, J. Río, M. Comabella, 2013, Clinical and experimental immunology.

Molecular signature associated with cladribine treatment in patients with multiple sclerosis

X. Montalban, U. Boschert, E. Sabidó, 2023, Frontiers in immunology.